Dataset Information


Contributions of degradation and brain-to-blood elimination across the blood-brain barrier to cerebral clearance of human amyloid-? peptide(1-40) in mouse brain.

ABSTRACT: The purpose of the present study was to estimate the relative contributions of degradation and brain-to-blood elimination processes to the clearance of microinjected human amyloid-? peptide(1-40) (hA?(1-40)) from mouse cerebral cortex, using a solid-phase extraction method together with a newly developed ultraperformance liquid chromatography/tandem mass spectrometry (UPLC/MS/MS) quantitation method for intact hA?(1-40). The clearance rate constant of hA?(1-40) in mouse cerebral cortex was determined to be 3.21 × 10(-2)/min under conditions where the saturable brain-to-blood elimination process across the blood-brain barrier (BBB) was expected to be saturated. Thus, this clearance rate constant should mainly reflect degradation. The [(125)I]hA?(1-40) elimination rate across the BBB under nonsaturating conditions was determined to be 1.48 × 10(-2)/min. Inhibition studies suggested that processes sensitive to insulin and phosphoramidon, which inhibit neprilysin, insulin-degrading enzyme, and endothelin-converting enzyme, are involved not only in degradation, but also in elimination of hA?(1-40). In conclusion, our results suggest a dominant contribution of degradation to cerebral hA?(1-40) clearance, and also indicate that a sequential process of degradation and elimination of degradation products is involved in cerebral hA?(1-40) clearance.

PROVIDER: S-EPMC3824175 | BioStudies |

REPOSITORIES: biostudies

Similar Datasets

| S-EPMC3162579 | BioStudies
| S-EPMC3965363 | BioStudies
2015-04-15 | MODEL1409240002 | BioModels
| S-EPMC3049501 | BioStudies
| S-EPMC3756545 | BioStudies
| S-EPMC4610013 | BioStudies
| S-EPMC6897558 | BioStudies
| S-EPMC5987944 | BioStudies
| S-EPMC8111754 | BioStudies
| S-EPMC5484315 | BioStudies